Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · IEX Real-Time Price · USD
4.261
+0.611 (16.75%)
At close: Mar 28, 2024, 4:00 PM
4.140
-0.121 (-2.84%)
After-hours: Mar 28, 2024, 6:22 PM EDT

Virpax Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-15.19-21.65-12.06-4.34-3.31-2.64
Share-Based Compensation
0.540.750.971.470.680.38
Other Operating Activities
4.793.06-3.461.481.50.46
Operating Cash Flow
-9.85-17.85-14.54-1.38-1.13-1.8
Share Issuance / Repurchase
0052.831.380.631.12
Debt Issued / Paid
00-1.50.070.50.55
Other Financing Activities
----0.05--
Financing Cash Flow
0051.331.41.131.67
Net Cash Flow
-9.85-17.8536.790.01-0.01-0.12
Free Cash Flow
-9.85-17.85-14.54-1.38-1.13-1.8
Free Cash Flow Per Share
-8.41-15.24-21.78-4.46-3.86-6.34
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).